About 61% of patients with stage I or II dMMR colon cancer achieved a pathologic complete response after a single cycle of neoadjuvant pembrolizumab, new data revealed.

An accurate new blood test for colon cancer, the fourth leading cause of cancer deaths in the US, has been reported.

Patients whose metastatic colorectal cancer has progressed following chemotherapy and who lack mutations in the RAS and BRAF ...

A promising experimental blood test has shown the ability to accurately detect colon cancer with 81% accuracy in patients and ...

Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says.

Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says.

The combination of Opdivo and Yervoy is supported by updated results as a standard of care for MSI-H or dMMR metastatic ...

A simple blood test has shown promising results in accurately detecting colon cancer, a deadly disease that is rising at an ...

The study, funded by Cancer Research UK, could lead to a blood test which will inform doctors which inflammatory bowel ...

A NEW method for detecting bowel cancer is more than 90 per cent accurate at predicting which higher risk people will develop ...

This method will brings us closer to a potential blood test that could help doctors identify which IBD patients are most at ...